Results

Total Results: 455 records

Showing results for "neoplasms malignant neoplasm".

281. Understanding and Analyzing MEPS Household Component Medical Condition Data (pdf file)
     meps.ahrq.gov/survey_comp/MEPS_condition_data.pdf
     January 01, 2009 - include high blood pressure, heart disease, stroke, emphysema, chronic bronchitis, high cholesterol, cancer … diseases  1,993  75.2  12.5  12.4  10, 254–258  Other care and screening  1,866  84.6  2.7  12.7  11–45  Cancer …   1,321  89  1.2  9.9  46, 47  Non‐malignant neoplasm  381  83.6  1.7  14.7  48  Thyroid disease  1,285 … 625,421 14 10, 254–258  Other care and screening 20,347,107 931,518 16 17,219,615 808,617 13 11–45  Cancer … 17,400,124 736,081 19 15,479,928 709,324 17 46, 47  Non-malignant neoplasm 4,708,789 327,107 37 3,936,964

282. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V23%20Definitions%20Manual.pdf
     August 01, 2006 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS 204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 DISORDERS … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROCS EX MALIG 346 346 MALIGNANCY, MALE REPRO SYSTEM, 347 346 MALIGNANCY, MALE REPRO SYSTEM, 348

283. The Medical Expenditure Panel Survey is a set of large-scale surveys of families and individuals, their medical providers, and employers across the United States.
     meps.ahrq.gov/survey_comp/MEPS_condition_data.shtml
     January 01, 2009 - include high blood pressure, heart disease, stroke, emphysema, chronic bronchitis, high cholesterol, cancer … 12.5 12.4 10, 254–258 Other care and screening 1,866 84.6 2.7 12.7 11–45 Cancer … 1,321 89.0 1.2 9.9 46, 47 Non-malignant neoplasm 381 83.6 1.7 14.7 48 … 258 Other care and screening 20,347,107 931,518 16 17,219,615 808,617 13 11–45 Cancer … 17,400,124 736,081 19 15,479,928 709,324 17 46, 47 Non-malignant neoplasm 4,708,789

284. Appendixcmultidx
     hcup-us.ahrq.gov/toolssoftware/ccs/AppendixCMultiDX.txt
     April 18, 2016 - neoplasms 46 47 2.16.1 Benign … neoplasm [47.] 47 2.16.2.1 Benign neoplasm of ovary … - 220 2.16.2.2 Benign neoplasm of colon … 2.16.2.4 Benign neoplasm of cerebral meninges - … 2252 2.16.2.5 Other and unspecified benign neoplasms

285. Most Common Diagnoses and Procedures in U.S. Community Hospitals, 1996
     hcup-us.ahrq.gov/reports/natstats/commdx/table1j.htm
     February 11, 2011 - Cancer of bladder [32] 10,019 18.79 0.03 … Cancer of pancreas [17] 2,706 5.14 0.01 … Secondary malignancies [42] 1,311 2.60 0.00 … Secondary malignancies [42] 10,713 21.70 0.03 … Other and unspecified benign neoplasm [47] 11,443 23.96 0.03

286. Microsoft Word - AF_Report2006_fin.doc (pdf file)
     hcup-us.ahrq.gov/reports/methods/2008_04.pdf
     January 01, 2008 - ; other and unspecified primary 1.00 1.00 0.97 1.04 1.02 0.99 0.95 42: Secondary malignancies 1.04 1.02 … Malignant neoplasm without specification of site 1.05 1.03 1.08 1.06 1.08 0.96 1.04 44. … Neoplasms of unspecified nature or uncertain behavior 0.98 0.97 0.96 1.00 0.96 1.03 0.96 45: Maintenance … chemotherapy; radiotherapy 0.95 0.92 0.94 0.99 0.92 1.01 0.97 46: Benign neoplasm of uterus 0.87 0.86 … 0.80 0.95 0.84 1.00 0.85 47: Other and unspecified benign neoplasm 0.93 0.92 0.88 0.98 0.92 1.00 0.91

287. Organisation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
     June 16, 2008 - Clinical study of proton radiotherapy in urological cancers [Japanese]. … Proton therapy for head and neck malignancies at Tsukuba. … Cancer Journal 2006 Apr;12(2):155-9. 16630407 No malignancy Makarova GV, Matveev BP, Leonova NS, … [Use of high energy protons in the combination treatment of cervix neoplasms] [Russian]. … Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form.

288. Maskedstats Nrd 2022 Dx Pr Grps (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2022_DX_PR_GRPS.PDF
     January 01, 2022 - 159,177 CMR_CANCER_LEUK : Leukemia 16,517,253 0 0.00 1.00 0.01 0 123,374 CMR_CANCER_METS : Metastatic cancer … 16,517,253 0 0.00 1.00 0.03 0 521,735 CMR_CANCER_NSITU : Solid tumor without metastasis, in situ 16,517,253 … 0 0.00 1.00 0.00 0 5,366 CMR_CANCER_SOLID : Solid tumor without metastasis, malignant 16,517,253 0 … 5.39% MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 663,072 4.01% NEOnnn: Neoplasms

289. Maskedstats Nrd 2021 Dx Pr Grps (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_DX_PR_GRPS.PDF
     January 01, 2021 - 157,399 CMR_CANCER_LEUK : Leukemia 16,805,508 0 0.00 1.00 0.01 0 120,660 CMR_CANCER_METS : Metastatic cancer … 16,805,508 0 0.00 1.00 0.03 0 510,954 CMR_CANCER_NSITU : Solid tumor without metastasis, in situ 16,805,508 … 0 0.00 1.00 0.00 0 5,214 CMR_CANCER_SOLID : Solid tumor without metastasis, malignant 16,805,508 0 … 5.62% MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 702,479 4.18% NEOnnn: Neoplasms

290. Maskedstats Nrd 2020 Dx Pr Grps (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_DX_PR_GRPS.PDF
     January 01, 2020 - 155,745 CMR_CANCER_LEUK : Leukemia 16,692,694 0 0.00 1.00 0.01 0 117,602 CMR_CANCER_METS : Metastatic cancer … 16,692,694 0 0.00 1.00 0.03 0 509,656 CMR_CANCER_NSITU : Solid tumor without metastasis, in situ 16,692,694 … 0 0.00 1.00 0.00 0 4,794 CMR_CANCER_SOLID : Solid tumor without metastasis, malignant 16,692,694 0 … 5.80% MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 854,722 5.12% NEOnnn: Neoplasms

291. Neds 2007V2 Maskedstats Core Weighted (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_Core_Weighted.PDF
     April 09, 2010 - 14: Cancer of colon 34,920 0.03 15: Cancer of rectum and anus 11,581 0.01 16: Cancer of liver and … ; other and unspecified primary 3,239 0.00 42: Secondary malignancies 131,834 0.11 43: Malignant neoplasm … without specification of site 4,842 0.00 44: Neoplasms of unspecified nature or uncertain behavior … 33,714 0.03 45: Maintenance chemotherapy; radiotherapy 4,468 0.00 46: Benign neoplasm of uterus 33,499 … 0.03 47: Other and unspecified benign neoplasm 53,592 0.04 48: Thyroid disorders 37,454 0.03 49:

292. Neds 2007 Maskedstats Core Weighted (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_Core_Weighted.PDF
     January 01, 2007 - 14: Cancer of colon 34,826 0.03 15: Cancer of rectum and anus 11,830 0.01 16: Cancer of liver and … ; other and unspecified primary 3,540 0.00 42: Secondary malignancies 129,279 0.11 43: Malignant neoplasm … without specification of site 4,722 0.00 44: Neoplasms of unspecified nature or uncertain behavior … 33,148 0.03 45: Maintenance chemotherapy; radiotherapy 5,281 0.00 46: Benign neoplasm of uterus 34,062 … 0.03 47: Other and unspecified benign neoplasm 54,805 0.04 48: Thyroid disorders 38,709 0.03 49:

293. Neds 2008 Maskedstats Core Weighted (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2008_MaskedStats_Core_Weighted.PDF
     January 01, 2008 - 14: Cancer of colon 35,317 0.03 15: Cancer of rectum and anus 11,280 0.01 16: Cancer of liver and … ; other and unspecified primary 3,229 0.00 42: Secondary malignancies 129,333 0.10 43: Malignant neoplasm … without specification of site 6,063 0.00 44: Neoplasms of unspecified nature or uncertain behavior … 34,086 0.03 45: Maintenance chemotherapy; radiotherapy 4,289 0.00 46: Benign neoplasm of uterus 35,571 … 0.03 47: Other and unspecified benign neoplasm 53,605 0.04 48: Thyroid disorders 38,390 0.03 49:

294. Maskedstats Nrd 2019 Dx Pr Grps V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_DX_PR_GRPS_V2.PDF
     January 01, 2019 - 127,782 CMR_CANCER_LYMPH : Lymphoma 18,132,856 0 0.00 1.00 0.01 0 173,295 CMR_CANCER_METS : Metastatic cancer … 18,132,856 0 0.00 1.00 0.03 0 549,521 CMR_CANCER_NSITU : Solid tumor without metastasis, in situ 18,132,856 … 0 0.00 1.00 0.00 0 5,650 CMR_CANCER_SOLID : Solid tumor without metastasis, malignant 18,132,856 0 … 5.84% MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 1,202,636 6.63% NEOnnn: Neoplasms

295. Renal-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
     April 20, 2015 - early-stage cancers, the death rate from kidney cancer has not changed significantly over the same … in the range of 0.55 to 0.65.[3, 16- 18] The best predictors of malignancy are male sex and tumor size … – who have the highest risk of having aggressive malignancies. … Given the increased incidence in early, low-stage tumors without improvement in cancer-related deaths … Frank, I., et al., Independent validation of the 2002 American Joint Committee on cancer primary tumor

296. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49682/psn-pdf
     April 01, 2013 - magnetic resonance imaging (MRI) of the head revealed parietal and frontal masses concerning for malignancy … alternate diagnoses such as transient ischemic attack or stroke, other structural brain lesions (e.g., neoplasm … Steroids, in particular, yield symptomatic improvement in many conditions, including brain tumors with … surrounding edema (the correct diagnosis in this case) or steroid-responsive brain neoplasms (e.g., … Internet search engines for information on possible diagnoses Asymptomatic patient (e.g., routine cancer

297. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V22%20Definitions%20Manual.pdf
     April 01, 2006 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS 204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 DISORDERS … 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 261 261 … PROCS EX MALIG 346 346 MALIGNANCY, MALE REPRO SYSTEM, 347 346 MALIGNANCY, MALE REPRO SYSTEM, 348

298. Hospital Inpatient Statistics, 1996
     hcup-us.ahrq.gov/reports/natstats/his96/clinclas.htm
     September 01, 1999 - How do the average mean charges for alternative treatments of benign uterine cancer compare? … ventricular fibrillation with mortality rates of 50 percent, followed by shock (49.8 percent) and malignant … neoplasm without specification of site (29.6 percent). … fibrillation (category 7.2.10), with a mortality rate of 50.0 percent; shock (17.1.5), 49.8 percent; and malignant … neoplasm without specification of site (2.13), 29.6 percent.

299. Protocol: Imaging for Pretreatment Staging of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
     December 08, 2014 - cell lung cancer (SCLC) comprises approximately 15% of all lung cancers.2 The five-year survival rate … Lung cancers are classified based on the size of the main tumor, whether it has locally invaded other … '/de OR cancer OR tumor* OR tumour* OR mass* OR neoplasm* AND (stage OR 'staging'/de OR staging OR class … OR tumor* OR tumour* OR mass* OR neoplasm*) AND (stage OR staging OR class*) Source: www.effectivehealthcare.ahrq.gov … [tiab] OR neoplasm[tiab] OR tumor*[tiab] OR tumour*[tiab]) AND (care[tiab] OR treatment[tiab] OR therapy

300. Characteristics of Inpatient Stays Involving Hepatitis C, 2005-2014 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb232-Hepatitis-C-Hospital-Stays-Trends.pdf
     June 19, 2017 - develop a chronic infection that can result in cirrhosis, liver failure, hepatocellular carcinoma (liver cancer … Liver cancer was most common among hepatitis C-plus stays at 7.7 percent. … 155.0 Malignant neoplasm of liver, primary 155.1 Malignant neoplasm of intrahepatic bile ducts 155.2 … Malignant neoplasm of liver, not specified as primary or secondary 197.7 Liver, specified as secondary … malignant neoplasm 230.8 Carcinoma in situ of liver and biliary system 235.3 Neoplasm of uncertain